James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Apple Pay Versus CurrentC: Which is Built to Last?

Apple Pay, Softcard, CurrentC and Google Wallet -- this fragmentation can't last forever. Here's the handicap of the race.

Is Google Stock Becoming a Healthcare Stock?

Google stock isn't likely to ever predominantly be a healthcare stock, but that's not to say healthcare won't be a key piece of its revenue.

MNKD: 17 Weeks and 58% Later, MannKind Stock FINALLY Is a Buy

MannKind Corporation (MNKD) has disappointed a lot of investors since Afrezza was approved in June, but the tide is finally turning for MannKind stock.

Facebook Earnings: What to Know Before Tuesday’s Report (FB)

Any fans and followers of FB stock have a few things to think about before Q3 Facebook earnings figures are posted Tuesday afternoon.

Mid-Caps Fell Off the Radar. Big Mistake.

Mid-caps have been outperforming other areas for five years now, and deservedly so. Here's why, and why that leadership isn't about to falter.